Skip to main content

Advertisement

SpringerLink
Log in

Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) patients have a high risk for cardiovascular events, but few studies have evaluated the recognition and none have evaluated the control of cardiovascular risk factors (RF) in SLE patients. The study aims to describe the recognition and control frequencies of systemic arterial hypertension (SAH), dyslipidemia, and diabetes mellitus (DM) in SLE patients. Of the female patients with SLE, 137 answered a questionnaire focused on general knowledge of the RF for coronary artery disease (CAD) and on recognition of the risk factors that they possess. The patient’s information collected on a structured medical record was reviewed to evaluate the RF control. The mean age was 29.1 (9.6) years. Seventy patients had SAH; 85.7% recognized their condition and 71.4% had desirable blood pressure (BP) control (< 140 × 90 mmHg). From a group of 63 patients with dyslipidemia, 68.3% recognized that they had dyslipidemia and 69.8% had desirable LDL-cholesterol (< 130 mg/dL). Sixteen patients had DM; 87.5% admitted being diabetic and 50.0% had desirable glycemic control (HbA1C < 7%). Most patients were aware of presenting SAH, DM, or dyslipidemia, and the recognition frequency was higher in comparison to general population. The SAH and dyslipidemia control frequencies were higher than that described for the general population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Urowitz MB, Bookman AA, Koehler BE et al (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225

    Article  PubMed  CAS  Google Scholar 

  2. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger RD, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337

    Article  PubMed  CAS  Google Scholar 

  3. Du Pasquier S, Aslani P (2008) Concordance-based adherence support service delivery: consumer perspectives. Pharm World Sci PWS 30:846–853. https://doi.org/10.1007/s11096-008-9237-0

    Article  PubMed  Google Scholar 

  4. Lee NL, Yu C-M, Lam Y-Y, Lee VW, Yan BP (2013) Patient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting. Int J Cardiol 166:278–279. https://doi.org/10.1016/j.ijcard.2012.09.147

    Article  PubMed  Google Scholar 

  5. Costenbader KH, Karlson EW, Gall V, Pablo P, Finckh A, Lynch M, Bermas B, Schur PH, Liang MH (2005) Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum 53:718–723. https://doi.org/10.1002/art.21441

    Article  PubMed  Google Scholar 

  6. Boulos D, Koelmeyer RL, Morand EF, Hoi AY (2017) Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us? Lupus Sci Med 4:e000212. https://doi.org/10.1136/lupus-2017-000212

    Article  PubMed  PubMed Central  Google Scholar 

  7. Associação Brasileira de Empresas de Pesquisa (2015) Critério de Classificação econômica Brasil. In: Critério Brasil ABEP www.abep.org/criterio-brasil Accessed 10 November 2015

    Google Scholar 

  8. Schoenborn CA (1988) Health promotion and disease prevention, United States, 1985. Vital and Health Statistics 163:88–1591

    Google Scholar 

  9. Xavier HT, Faria Neto JR, Assad MH et al (2013) V Brazilian guidelines on dyslipidemias and prevention of atherosclerosis. Arq Bras Cardiol 101:1–20. https://doi.org/10.5935/abc.2013S010

    Article  CAS  PubMed  Google Scholar 

  10. American Diabetes Association (2015) Classification and diagnosis of diabetes. Diabetes Care 38:S8–S16. https://doi.org/10.2337/dc15-S005

    Article  Google Scholar 

  11. Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensão/Sociedade Brasileira de Nefrologia (2010) VI Diretrizes brasileiras de hipertensão. Arq Bras Cardiol 95(1 supl. 1):1–51

    Google Scholar 

  12. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, Gilburd B, Corbanese S, Patnaik M, Zampieri S, Peter JB, Favaretto E, Iaccarino L, Sherer Y, Todesco S, Pauletto P (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071–1077

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Scalzi LV, Ballou SP, Park JY, Redline S, Kirchner HL (2008) Cardiovascular disease risk awareness in systemic lupus erythematosus patients. Arthritis Rheum 58:1458–1464. https://doi.org/10.1002/art.23419

    Article  PubMed  Google Scholar 

  14. Bruce IN, Urowitz MB, Gladman DD, Ibañez D, Steiner G (2003) Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study. Arthritis Rheum 48:3159–3167. https://doi.org/10.1002/art.11296

    Article  PubMed  Google Scholar 

  15. Telles RW, Lanna CCD, Ferreira GA, Souza AJ, Navarro TP, Ribeiro AL (2008) Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting. Lupus 17:105–113. https://doi.org/10.1177/0961203307085312

    Article  PubMed  CAS  Google Scholar 

  16. Costenbader KH, Wright E, Liang MH, Karlson EW (2004) Cardiac risk factor awareness and management in patients with systemic lupus erythematosus. Arthritis Care Res 51:983–988. https://doi.org/10.1002/art.20824

    Article  Google Scholar 

  17. Jiménez S, García-Criado MA, Tàssies D et al (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatol Oxf Engl 44:756–761. https://doi.org/10.1093/rheumatology/keh581

    Article  Google Scholar 

  18. Petri M, Spence D, Bone LR, Hochberg MC (1992) Coronary artery disease risk factors in the Johns Hopkins lupus cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore) 71:291–302

    Article  CAS  Google Scholar 

  19. Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, Pécoud A, Hayoz D, Mooser V, Waeber G, Vollenweider P (2009) Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil 16:66–72. https://doi.org/10.1097/HJR.0b013e32831e9511

    Article  PubMed  Google Scholar 

  20. McDonald M, Hertz RP, Unger AN, Lustik MB (2009) Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci 64:256–263. https://doi.org/10.1093/gerona/gln016

    Article  PubMed  Google Scholar 

  21. Chor D, Pinho Ribeiro AL, Sá Carvalho M, Duncan BB, Andrade Lotufo P, Araújo Nobre A, Aquino EMLL, Schmidt MI, Griep RH, Molina MDCB, Barreto SM, Passos VMA, Benseñor IJM, Matos SMA, Mill JG (2015) Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: results of the ELSA-Brasil study. PLoS One 10:e0127382. https://doi.org/10.1371/journal.pone.0127382

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. He H, Yu Y, Li Y, Kou CG, Li B, Tao YC, Zhen Q, Wang C, Kanu J, Huang XF, Han M, Liu YW (2014) Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study. Lipids Health Dis 13:122. https://doi.org/10.1186/1476-511X-13-122

    Article  PubMed  PubMed Central  Google Scholar 

  23. Huang Y, Gao L, Xie X, Tan SC (2014) Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control. Popul Health Metrics 12:28. https://doi.org/10.1186/s12963-014-0028-7

    Article  Google Scholar 

  24. Alkerwi A, Pagny S, Lair M-L et al (2013) Level of unawareness and management of diabetes, hypertension, and dyslipidemia among adults in Luxembourg: findings from ORISCAV-LUX study. PLoS One 8:e57920. https://doi.org/10.1371/journal.pone.0057920

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Mankad R (2015) Atherosclerotic vascular disease in the autoimmune rheumatologic patient. Curr Atheroscler Rep 17:497. https://doi.org/10.1007/s11883-015-0497-6

    Article  PubMed  CAS  Google Scholar 

  26. Urowitz MB, Gladman DD, Ibanez D, Berliner Y (2006) Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study. Ann Rheum Dis 65:115–117. https://doi.org/10.1136/ard.2005.038802

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC (2012) Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One 7:e48255. https://doi.org/10.1371/journal.pone.0048255

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Fasce E, Campos I, Ibáñez P et al (2007) Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens 25:1807–1811. https://doi.org/10.1097/HJH.0b013e328244e481

    Article  PubMed  CAS  Google Scholar 

  29. Guo F, He D, Zhang W, Walton RG (2012) Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 60:599–606. https://doi.org/10.1016/j.jacc.2012.04.026

    Article  PubMed  Google Scholar 

  30. McAlister FA, Wilkins K, Joffres M et al (2011) Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ Can Med Assoc J 183:1007–1013. https://doi.org/10.1503/cmaj.101767

    Article  Google Scholar 

  31. Goff DC, Bertoni AG, Kramer H et al (2006) Dyslipidemia prevalence, treatment, and control in the multi-ethnic study of atherosclerosis (MESA) gender, ethnicity, and coronary artery calcium. Circulation 113:647–656. https://doi.org/10.1161/CIRCULATIONAHA.105.552737

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This study was financially supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Dr. Ribeiro was supported in part by CNPq (Bolsa de produtividade em pesquisa, 310679/2016-8) and by FAPEMIG (Programa Pesquisador Mineiro, PPM-00428-17).

Author information

Authors and Affiliations

  1. Hospital das Clínicas e Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Av. Professor Alfredo Balena, 190, Belo Horizonte, Minas Gerais, 30130-100, Brazil

    Luísa Lima Castro, Cristina Costa Duarte Lanna, Antônio Luiz Pinho Ribeiro & Rosa Weiss Telles

Authors
  1. Luísa Lima Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristina Costa Duarte Lanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antônio Luiz Pinho Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rosa Weiss Telles
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luísa Lima Castro.

Ethics declarations

Disclosures

None.

Ethical approval

This study was approved by the UFMG Research Ethics Committee (CAAE 06992112.7.0000.5149) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All enrolled subjects signed an informed consent prior to their inclusion in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Castro, L.L., Lanna, C.C.D., Ribeiro, A.L.P. et al. Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus. Clin Rheumatol 37, 2693–2698 (2018). https://doi.org/10.1007/s10067-018-4169-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4169-0

Keywords

Search

Navigation